Gastrointestinal basidiobolomycosis (GIB) is an unusual fungal infection that is rarely reported in the medical literature. From April 1994 through May 1999, 7 cases of GIB occurred in Arizona, 4 from December 1998 through May 1999. We reviewed the clinical characteristics of the patients and conducted a case-control study to generate hypotheses about potential risk factors. All patients had histopathologic signs characteristic of basidiobolomycosis. Five patients were male (median age, 52 years; range, 37-59 years) and had a history of diabetes mellitus (in 3 patients), peptic ulcer disease (in 2), or pica (in 1). All patients underwent partial or complete surgical resection of the infected portions of their gastrointestinal tracts, and all received itraconazole postoperatively for a median of 10 months (range, 3-19 months). Potential risk factors included prior ranitidine use and longer residence in Arizona. GIB is a newly emerging infection that causes substantial morbidity and diagnostic confusion. Further studies are needed to better define its risk factors and treatment.
Basidiobolomycosis is a rare disease caused by the fungus
Basidiobolus ranarum, an environmental saprophyte found worldwide [1] . B. ranarum is a member of the order Entomophthorales, of the class Zygomycetes [1] . Other medically important zygomycetes are in the order Mucorales and collectively cause mucormycosis [1] . Basidiobolomycosis is usually a subcutaneous infection that affects mostly young, male persons, and it is transmitted through traumatic inoculation [1] [2] [3] [4] [5] . Most cases have been reported from tropical and subtropical climates, mainly East and West Africa and Indonesia [1, [3] [4] [5] [6] [7] [8] [9] [10] [11] . Gastrointestinal basidiobolomycosis (GIB) is exceedingly rare; only 15 cases have been reported worldwide (2 cases if culture was not done, on the basis of a histologic appearance characteristic of entomophthoramycosis.
Case finding. To enable the identification of additional cases, a letter with a histologic description of basidiobolomycosis was sent to pathologists, infectious disease specialists, and gastroenterologists throughout Arizona. In addition, local dermatologists were contacted regarding possible cases of subcutaneous basidiobolomycosis. To increase awareness of this disease, an article was published by the Centers for Disease Control and Prevention (CDC) in the Morbidity and Mortality Weekly Report (MMWR) [21] . We also contacted the Armed Forces Institute of Pathology regarding any additional cases of basidiobolomycosis in Arizona.
Medical record reviews. Both inpatient and outpatient medical records were reviewed, and data were collected about symptoms, medical and social history, laboratory and radiological examinations, procedures, treatment, and outcome.
Culture and histopathology confirmation. The identification of 3 patient isolates was confirmed at the Fungus Reference Laboratory Unit of the CDC on the basis of morphological appearance. Macroscopically on Sabouraud agar, colonies have a waxy, yellowish-to-gray appearance with many radial folds [1] . On microscopic examination, B. ranarum can be identified by characteristically beaked zygospores (figure 1). Two pathologists (T. C. and J. G.) separately reviewed the histologic materials. Evaluated features included anatomic site, state of the mucosal lining, granulomatous inflammation, tissue eosinophilia, necrosis, fungal elements consistent with zygomycosis, and structures showing Splendore-Hoeppli phenomenon (radiating, intensely eosinophilic granular material surrounding the fungal elements).
Serological testing for B. ranarum. At least one serum sample from each patient was analyzed at the CDC for antibodies to B. ranarum; an immunodiffusion method was used, as described elsewhere [22] , except that the assay was done with the micro-immunodiffusion format [23] . Patient serum samples were incubated with reference antisera and thimerosaltreated culture filtrate for 24-48 h in a humid chamber. A patient serum sample was considered to be positive if у1 precipitin bands matched any of the 4 precipitin bands of the reference antisera.
Antifungal drug susceptibility testing. Isolates of B. ranarum were tested for susceptibility to amphotericin B, itraconazole, and ketoconazole, according to National Committee for Clinical Laboratory Standards (NCCLS) guidelines for filamentous fungi [24] . In brief, the drugs were dissolved in dimethyl sulfoxide and were diluted with RPMI-1640 medium to give a final concentration range of 0.03-16 mg/mL. Isolates were subcultured on potato dextrose agar slants at 35ЊC for 7 days. Spore suspensions were prepared in RPMI-1640 medium and were adjusted to a final inoculum of 0.4-cfu/mL. 4 5 ϫ 10 Broth microdilution MICs were determined in microtiter plates after incubation at 35ЊC for 48 hours. The MIC of amphotericin B was defined as the lowest concentration at which there was complete inhibition of growth; the MIC of itraconazole and ketoconazole was defined as the lowest concentration at which there was prominent or complete inhibition of growth, compared with that of the drug-free controls.
Case-control study. Four control subjects were enrolled for each case patient, matched by age ‫5ע(‬ years), with exclusion of HIV-infected persons and those with inflammatory bowel disease. Two control groups were identified: one group with patients who were chosen randomly from gastroenterology clinics and one with patients who were from each case patient's neighborhood. Two control subjects per case patient were selected from each group. Clinic-based control subjects were identified by systematically searching the registration logs of the gastroenterology clinics where patients were evaluated before diagnosis of GIB. After informed consent was obtained, case patients and control subjects were administered a questionnaire (filled out by G. M. L.) about job and recreational activities, medical history, home and work environment, contact with animals, and diet. Patients with GIB were also asked about their symptoms and medical care.
Statistical analysis. Univariate analysis was done by the use of a stratified (matched) Mantel-Haenszel method using Epi Info, version 6.04 (CDC). For continuous variables, an exact logistic regression was done by use of LogXact (Cytel). Statistical analysis was initially conducted separately for each control group. Because comparison of initial findings did not reveal significant differences between the control groups, the final analysis presented here was repeated with the 2 control groups considered as 1 set, to improve the power of the study.
RESULTS

Clinical and demographic characteristics.
No additional cases were identified, even after publication of the MMWR article [21] and a search of the database of the Armed Forces Institute of Pathology. Table 1 provides detailed clinical, laboratory, and surgical characteristics of all 7 patients. The clinical characteristics of patients 1-3 have been reported elsewhere [14, 25, 26] , and the pathologic findings for the first 6 patients were described by Yousef et al. [18] . Of the 7 patients identified, 5 (71%) were male and 2 (29%) were black. The median age was 52 years (range, 37-59 years), and all patients resided in Arizona at the onset of their symptoms. Apart from residence in Arizona and the fact that patients 3 and 4 lived in the same trailer park, no other epidemiological link was established among these patients.
All 7 patients had abdominal pain as a presenting symptom; only 2 (28%) had fever. All patients had leukocytosis and eosinophilia preoperatively, which rapidly resolved after excision of the inflammatory mass. Abdominal CT scanning and barium enema examination findings were abnormal, usually revealing gastrointestinal tract masses, which occasionally involved adjacent organs. Four of the 7 cases were diagnosed preoperatively as cancer, 2 as inflammatory bowel disease, and 1 as diverticulitis. Table 2 summarizes the pathological findings. The colon was the most frequently involved portion of the gastrointestinal tract. Microscopically, eosinophilic inflammation was prominent, but the characteristic Splendore-Hoeppli reaction was not uniformly noted. Fungal elements were present in all pathological specimens. After surgery, patients were treated for a median of 10 months (range, 3-19 months). Patient 3 also was treated with terbinafine for 2 months because of the slow resolution of abnormalities seen on CT. The details concerning 2 representative patients are given here.
Patient 2. A 46-year-old landscaper was hospitalized in September 1996. He was an alcoholic and for the previous week had had a painful right-lower-quadrant abdominal mass. A barium enema revealed an "apple core" lesion in the descending colon; CT scanning showed a left-hepatic-lobe lesion and a mass involving the ileocecal area, psoas, and retroperitoneum. Laparotomy revealed a large mass involving the retroperitoneum, cecum, appendix, and a loop of small bowel. Also found was a 4-cm omental mass overlying the left lobe of the liver. The omental mass, descending colon, appendix, and a portion of cecum were resected. Histopathologic examination showed a necrotizing, granulomatous process, with a prominent Splendore-Hoeppli reaction surrounding spores and septate hyphae ( figure 2) .
B. ranarum was cultured from the surgical specimens. Antifungal susceptibility testing of the isolate demonstrated susceptibility to itraconazole and resistance to amphotericin B and fluconazole. The patient was treated with oral itraconazole (200 mg given twice per day) for 19 months following surgery, during which time all radiographically evident disease resolved. The patient remained asymptomatic for 11 year after the withdrawal of itraconazole.
Patient 4. In October 1998, a 52-year-old man with controlled type 2 diabetes mellitus, who resided at the same trailer park as patient 3, saw his physician because of abdominal pain of 10 days' duration. A gastroenterologist who was consulted later diagnosed diverticulitis and prescribed ciprofloxacin. As symptoms persisted, a CT scan demonstrated sigmoid colon diverticula and a -cm inflammatory mass of the sigmoid 6 ϫ 10 colon. Laboratory studies disclosed a leukocyte (WBC) count of cells/mm 3 , with eosinophilia as high as 14.3%. The 6 12.8 ϫ 10 patient underwent resection of the descending and sigmoid colon and partial excision of the mass. Histopathology revealed marked bowel-wall thickening with dense eosinophilic granulomatous infiltrates containing numerous broad hyphal structures. Culture of the surgical specimens did not yield B. ranarum. The patient also had specific B. ranarum antibodies in his serum. Administration of oral itraconazole (400 mg daily) was started after surgery. Six months later, at the time of reanastamosis, a 12-cm segment of diseased large bowel was found and resected. The resected bowel contained transmural necrotizing granulomas with septate fungal hyphae. Oral itraconazole therapy was continued postoperatively for 4 months, for a total of 10 months. The patient remained asymptomatic for 14 months after itraconazole therapy ended.
Serological and antifungal drug susceptibility testing. Immunodiffusion testing demonstrated that the serum samples obtained from 6 (83%) of 7 patients had у1 band of identity similar to 1 of the 4 precipitin bands observed in the reference antisera. Only patient 6 had no serological response, but his serum specimens were obtained 4 weeks and 4 months after surgery, after itraconazole therapy was started. Serial specimens were obtained from patients 1-6; reactivity in patients 1, 2, and 4 waned during a median of 5 months. However, patient 3 was still seropositive for р16 months after starting treatment. Two of 3 B. ranarum isolates received at the CDC remained viable. In susceptibility testing, the MICs of amphotericin B were both 2 mg/mL, the MICs of itraconazole were 1 mg/mL and 2 mg/ mL, and the MICs of ketoconazole were both 2 mg/mL. Case-control study. Table 3 summarizes the results of the case-control study. Before the onset of symptoms, ranitidine was taken by more case patients than control subjects (OR, 6.0; CI, 1-36; ). Case patients had smoked for more years P p .05 than did control subjects (OR, 2.1/additional 20 years of smoking; CI, 0.9-66;
). Digging earth as part of one's job P p .09 and the length of residence in Arizona also trended toward significance. Some factors did not reach statistical significance, presumably because of the small sample size, but demonstrated marked differences in frequency between case patients and control subjects. These factors were prior steroid use and use of over-the-counter drugs, owning a dog, and eating unwashed vegetables. Patient 5 had a history of pica and consumed dirt daily for the year before the diagnosis of GIB.
DISCUSSION
GIB appears to be an emerging infection in Arizona. Because it is a recently described disease, there is little awareness of it in the medical community, which resulted in delayed diagnosis and extensive morbidity among the patients we studied.
Because of the nonspecific presenting signs and symptoms, GIB may masquerade as another clinical entity, delaying definitive diagnosis and treatment. However, several clinical characteristics should raise suspicion for GIB. Patients in this study had a subacute onset of symptoms, usually beginning with abdominal pain, but failed to respond to the initially prescribed therapy. Radiographic findings were consistent with either malignancy or inflammation, but histopathologic tests revealed inflammatory changes with many eosinophils. All patients had elevated WBC counts with eosinophilia, which has been previously associated with systemic mycoses like coccidioidomycosis [27] but rarely with gastrointestinal malignancies or inflammatory bowel disease [27, 28] . Physicians should suspect GIB if a patient's clinical findings are unusual for the working diagnosis, response to therapy is poor, peripheral eosinophilia is present, and biopsy specimen shows eosinophilic inflammation. Confirmatory fungal cultures and fungal staining should always be done on biopsy specimens from patients with unusual gastrointestinal masses.
B. ranarum can be isolated from surgical specimens [1] . However, media should be inoculated soon after resection because B. ranarum does not survive at 4ЊC [1] . Sabouraud agar is an adequate medium, and visible growth is usually present 2-3 days after incubation at 25ЊC-30ЊC [1] . Colonies appear white or pale gray and have radial folds [1] . Surgically resected specimens can be directly stained with Gomori methenamine silver (GMS) or periodic acid-Schiff (PAS) [1, 18, 29] . The fungal elements will appear as broad, pleomorphic, sparsely septated hyphae, of which the walls stain faintly with fungal preparations (GMS or PAS stain) [1, 18, 21, 29] . On hematoxylin and eosin staining, the fungal elements often appear as empty spaces surrounded by an intensely staining eosinophilic material (Splendore-Hoeppli phenomenon) [1, 18, 21, 29] . The abundant eosinophilic inflammation in affected tissues helps distinguish basidiobolomycosis from mucormycosis, which usually is characterized by a neutrophilic infiltrate and vascular invasion with thrombosis [18, 29] . In the cases presented, the histopathology and fungal morphology, although nonspecific, were characteristic of entomophthorales infection. Since the 3 culture-proven cases had similar histopathologic features, it is reasonable to assume that all cases represent basidiobolus infection. Definitive diagnosis requires culture of the organism. If culture for B. ranarum is not done or if the result is negative, serodiagnosis with immunodiffusion can be employed as an adjunctive diagnostic method [22, 30] . The test appears to be very specific for B. ranarum, with no cross-reactivity with other species of the order Entomophthorales, but its sensitivity has not been determined [22, 30] . The test also appears useful for follow-up of response to therapy [14] .
B. ranarum has been isolated from soil and decaying vegetation throughout the world, including several southern states in the United States [1, [31] [32] [33] . Okafor et al. [32] isolated B. ranarum from several species of reptiles and amphibians in Florida. The subcutaneous form of the disease has been reported mainly from tropical Africa and sporadically from Asia, Australia, and South America [2-5, 7, 9, 16, 34, 35] , usually tropical or subtropical areas. The emergence of GIB in the desert southwest of the United States is puzzling, especially in the absence of subcutaneous disease. The rapid growth of the Phoenix metropolitan area may contribute to an increase in exposures to the natural reservoirs of B. ranarum. Most of this growth has been from immigration of an aging population, a factor that has been cited as important in the emergence of infectious diseases [36] .
The case-control study was conducted to identify potential risk factors for GIB and to generate hypotheses for further research. Owing to sample size limitations, few associations reached statistical significance, but many were suggestive of possible modes of exposure. Ranitidine may contribute to the pathogenesis of GIB by decreasing stomach acidity and allowing the organism to survive gastric passage, which was identified as a risk factor for bacterial gastroenteritis [37] [38] [39] . A longer duration of smoking also was identified as a potential risk factor. Smoking adversely affects mucosal WBC function, possibly facilitating infection with B. ranarum [40] .
It is unclear how the fungus is introduced into the host's gastrointestinal tract; however, the case-control study findings suggest that this occurs through ingestion of soil, animal feces, or food contaminated by either. Previous reports [4, 12-17, 25, 26] have suggested that ingestion and rectal inoculation seem to be the most likely routes of infection [12, 13, 16] . The association between duration of residence in Arizona and GIB probably indicates an increased chance of environmental exposure to B. ranarum. Attempts to culture B. ranarum from environmental specimens have been unsuccessful. No specific environmental source was implicated by our study, but identifying and quantifying exposures to environmental mycoses have usually proved to be very difficult, especially in nonoutbreak situations [41] [42] [43] [44] .
On the basis of the limited information from the cases reviewed here, it appears that optimal treatment of GIB combines surgical and medical methods. Patients should undergo resection of all affected bowel and debridement of other involved tissues, followed by у3 months of antifungal therapy. The best choice of antifungal agent is not clear, but the use of itraconazole seems to be reasonable, based on this experience and the literature [13-15, 18-20, 25, 26, 45] . Clinical failure has been described in association with amphotericin B [15, 19, 26] ; both here and in previous studies, in vitro testing has demonstrated high MICs of amphotericin B [45, 46] . Potassium iodide has been used successfully for treatment of subcutaneous basidiobolomycosis [2, 4, 5, 7, 34, 35, 47] but not GIB.
GIB may be emerging as a result of various environmental and demographic factors, such as migration of susceptible persons to areas that were not previously populated. Increased awareness of this clinical entity will lead to earlier diagnosis and probably less morbidity. As more cases become reported, larger studies may improve our understanding of the risk factors for this disease and ways to prevent it.
